Could 3-D conformal radiotherapy improve the overall survival for non-small cell lung cancer?;Cancers bronchiques non à petites cellules: Amélioration des chances de survie par la radiothérapie conformationnelle?

Cancer/Radiotherapie

Volumn 6, Issue SUPPL. 1, 2002, Pages

  Giraud, P ^a   Helfre, S ^a   Lavole, A ^a   Rosenwald, J C ^a   Cosset, J M ^a  

^a INSTITUT CURIE   (France)

Author keywords

Intensity modulated radiotherapy; Non small cell lung cancer; Three dimensional conformal radiotherapy

Indexed keywords

BREATHING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONFERENCE PAPER; DOSIMETRY; GEOMETRY; IMAGING; IMMOBILIZATION; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RADIATION DOSE; RADIATION EXPOSURE; SURVIVAL; TECHNIQUE; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 18244416356     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. Abratt RP. Dose-effect relationships for functional local injury after lung irradiation. Radiother Oncol 1996;38:175.
2. Armstrong J, Mc Gibney C. The impact of three-dimensional radiation on the treatment of non-small cell lung cancer. Radiother Oncol 2000;56:157-67.
3. Armstrong J, Raben A, Zelefsky M, Burt M, Leibel S, Burman C, et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 1997;44:17-22.
4. Armstrong JG, Burman C, Leibel S, Fontenla D, Kutcher G, Zelefsky M, et al. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high-dose radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 1993;26:685-9.
5. Armstrong JG. Three-dimensional conformal radiotherapy. Precision treatment of lung cancer. Chest Surg Clin North Am 1994;4:29-43.
6. Arriagada R, Le Chevalier T, Quoix E, Ruffie P, Martin M. Tarayre M, et al. Chemotherapy effect on locally advanced non small cell lung carcinoma: A randomized study of 353 patients. Int J Radiat Oncol Biol Phys 1991;20:1183-90.
7. Boersma LJ, Damen EMF, De Boer RW, Muller SH, Waldes Olmos RA, Van Zandwijk N, et al. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol 1995;36:15-23.
8. Broderick LS, Tarver RD, Conces DJ. Imaging of lung cancer: Old and new. Semin Oncol 1997;24:411-8.
9. Brugmans MJP, Van Der Horst A, Lebesque JV, Mijnheer BJ. Beam intensity modulation to reduce the field sizes for conformal irradiation of lung tumors: A dosimetric study. Int J Radiat Oncol Biol Phys 1999;43:893-904.
10. Carbone DP. The biology of lung cancer. Semin Oncol 1997;24:388-401.
11. Caselles O, Courbon F, Giraud P, Bachaud JM, François P. Arboucalot F, et al. Validation of a SPECT and CT image registration method of the chest. Phys Med 1998;14:87.
12. Darmon P. Les Cellules Folles. Paris: Eds. Plon; 1995.
13. Derycke S, De Gersem WRT, Van Duyse BBR, De Neve WCJ. Conformal radiotherapy of stage III non-small cell lung cancer: A class solution involving non-coplanar intensity-modulated beams. Int J Radiat Oncol Biol Phys 1998;41:771-7.
14. Derycke S, Van Duyse BBR, De Gersem WRT, De Wagter C, De Neve WCJ. Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer. Radiother Oncol 1997;45:253-61.
15. Emami B, Purdy JA, Manolis J, Barest G, Cheng E, Coia L, et al. Three-dimensional treatment planning for lung cancer. Int J Radiat Oncol Biol Phys 1991;21:217-27.
16. Emami B. Three-dimensional conformal radiation therapy in bronchogenic carcinoma. Semin Radiat Oncol 1996;6:92-7.
17. Erdi YE, Rosenzweig KE, Erdi AK, Macapinlac HA, Hu YC, Braban LE, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002;62:51-450.
18. Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999;17:2692-9.
19. Giraud P, De Rycke Y, Dubray B, Helfre S, Voican D, Guo L, et al. Conformal radiotherapy (CRT) planning for lung cancer: Analysis of intrathoracic organ motion during extreme phases of breathing. Int J Radiat Oncol Biol Phys 2001;51:1081-92.
20. Giraud P, Grahek D, Montravers F, Carette MF, Deniaud-Alexandre E, Julia F, et al. Contribution of CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 2001;50:1249-57.
21. Graham MV, Matthews JW, Harms WB, Emami B, Glazer HS, Purdy JA. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. Int J Radiat Oncol Biol Phys 1994;29:1105-17.
22. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45:323-9.
23. Graham MV, Purdy JA, Emami B, Matthews JW, Harms WB. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1995;33:993-1000.
24. Hayman JA, Martel MK, Ten Haken RK, Normolle DP, Todd III RF, Littles JF, et al. Dose escalation in non-small cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial. J Clin Oncol 2001;19:127-36.
25. Hazuka MB, Turrisi AT, Lutz ST, Martel MK, Ten Haken RK, Strawderman M, et al. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis. Int J Radiat Oncol Biol Phys 1993;27:273-84.
26. Hodapp N, Boesecke R, Schlegel W, Bruggmoser G, Wannenmacher M. Three-dimensional treatment planning for conformation therapy of a bronchial carcinoma. Radiother Oncol 1991;20:245-9.
27. Intensity-Modulated Radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51:880-914.
28. Jacobs I, Vanregemorter J, Scalliet P. Influence of respiration on calculation and delivery of the prescribed dose in external radiotherapy. Radiother Oncol 1996;39:123-8.
29. Lagerwaard FJ, Senan S, van Meerbeeck JP, Graveland WJ. Has 3-D conformal radiotherapy (3DCRT) improved the local tumor control for stage I non-small cell lung cancer? Radiother Oncol 2002;63:151-7.
30. Leibel SA, Armstrong JG, Kutcher GJ, Zelefsky MS, Burman CM, Mohan R, et al. 3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center. Front Radiat Ther Oncol 1996;29:199-206.
31. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-60.
32. Mah K, Caldwell CB, Ung YC, Danjoux CE, Balogh JM, Gangulis N, et al. The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study. Int J Radiation Biol Phys 2002;52:339-50.
33. Mah K, Van Dick J, Keane T, Poon PY. Acute radiation-induced pulmonary damage: A clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1987;13:179-88.
34. Marks LB, Sibley G. The rationale and use of three-dimensional radiation treatment planning for lung cancer. Chest 1999;116:539S-44S.
35. Martel MK, Eisbruch A, Lawrence TS, Fraass BA, Ten Haken RK, Lichter AS. Spinal cord dose from standard head and neck irradiation: Implications for three-dimensional treatment planning. Radiother Oncol 1998;47:185-9.
36. Martel MK, Strawderman M, Hazuka MB, Kessler ML, Strawderman M, Turrisi AT, et al. Volume and dose parameters for survival of non-small cell lung cancer patients. Radiother Oncol 1997;44:23-9.
37. Martel MK, Ten Haken RK, Hazuka MB. Estimation of tumor control probability parameters from 3D dose distributions of non-small cell lung cancer patients. Lung Cancer 1999;24:31-7.
38. McGibney C, Holmberg O, McClean B, Williams C, McCrea P, Sutton P, et al. Dose escalation of CHART in non-small cell lung cancer: Is three-dimensional conformal radiation therapy really necessary? Int J Radiat Oncol Biol Phys 1999;45:339-50.
39. Meeks SL, Buatti JM, Bova FJ, Friedman WA, Mendenhall WM, Zlotecki RA. Potential clinical efficacy of intensity-modulated conformal therapy. Int J Radiat Oncol Biol Phys 1998;40:483-95.
40. Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2001;49:23-33.
41. Mohan R, Wang X, Jackson A, Bortfeld T, Boyer AL, Kutcher GJ, et al. The potential and limitations of the inverse radiotherapy technique. Radiother Oncol 1994;32:232-48.
42. Monson JM, Stark P, Reilly JJ, Sugarbaker DJ, Strauss GM, Swanson SJ, et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998;82:842-50.
43. Oetzel D, Schraube P, Hensley F, Sjoka-Perez G, Menke M, Flentje M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995;33:455-60.
44. Perez CA, Bauer M, Edelstein S, Gillespie BW, Birch R. Impact of tumor control on survival of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 1986;12:539-47.
45. Roberston JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1079-85.
46. Rosenzweig KE, Hanley J, Mah D, Mageras G, Hunt M, Toner S, et al. The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2000;48:81-7.
47. Rosenzweig KE, Mychalczak B, Fuks Z, Hanley J, Burman C, Ling CC, et al. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. Cancer J 2000;6:66-8.
48. Sailer SL, Rosenman JG, Soltys M, Cullip TJ, Chen J. Improving treatment planning accuracy through multimodality imaging. Int J Radiat Oncol Biol Phys 1996;35:117-24.
49. Saunders M, Dische S, Bennett A. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomized multicenter trial. Lancet 1997;350:161-5.
50. Sause W, Kolesar P, Taylor SIV, Johnson D, Livingston R, Komaki R, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer (RTOG, ECOG & SWOG). Chest 2000;117:358-64.
51. Seppenwoolde Y, Engelsman M, De Jaeger K, Muller SH, Baas P, McShan DL, et al. Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol 2002;63:165-77.
52. Sibley GS, Mundt AJ, Shapiro C, Jacobs R, Chen G, Weichselbaum R, et al. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. Int J Radiat Oncol Biol Phys 1995;33:1001-7.
53. Van Sornsen de Koste JR, Voet P, Dirkx M, van Meerbeeck J, Senan S. An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer. Lung Cancer 2001;32:145-53.
54. Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol 1999;9:78-98.
55. Vijayakumar S, Myrianthopoulos LC, Rosenberg I, Halpern HJ, Low N. Chen GTY. Optimization of radical radiotherapy with beam's eye view techniques for non-samll cell lung cancer. Int J Radiat Oncol Biol Phys 1991:21:779-88.
56. Wong JW, Sharpe MB, Jaffray DA, Kini VR, Roberstson JM, Stromberg JS, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 1999;44:911-9.
57. Yorke Ed, Wang L, Rosenzweig KE, Mah D, Paoli JB, Chui CS. Evaluation of deep inspiration breath-hold lung treatment plans with Monte Carlo dose calculation. Int J Radiat Oncol Biol Phys 2002;53:1058-70.
58. Yu CX, Jaffray DA, Wong JW. The effects of intra-fraction organ motion on the delivery of dynamic intensity modulation. Phys Med Biol 1998;43:91-104.